XML 92 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Investments in and Advances to Unconsolidated Joint Ventures
12 Months Ended
Dec. 31, 2011
Investments in and Advances to Unconsolidated Joint Ventures  
Investments in and Advances to Unconsolidated Joint Ventures

(8) Investments in and Advances to Unconsolidated Joint Ventures

  • HCP Ventures II

        On January 14, 2011, the Company acquired its partner's 65% interest in HCP Ventures II, a joint venture that owned 25 senior housing facilities, becoming the sole owner of the portfolio.

        The HCP Ventures II consideration is as follows (in thousands):

 
  January 14,
2011
 

Cash paid for HCP Ventures II's partnership interest

  $ 135,550  

Fair value of HCP's 35% interest in HCP Ventures II (carrying value of $65,223 at closing)(1)

    72,992  
       

Total consideration

  $ 208,542  
       

Estimated fees and costs

       

Legal, accounting and other fees and costs(2)

  $ 150  

Debt assumption fees(3)

    500  
       

Total

  $ 650  
       

(1)
The Company recognized a gain of approximately $8 million, included in other income, net, which represents the fair value of the Company's 35% interest in HCP Ventures II in excess of its carrying value on the acquisition date.

(2)
Represents estimated fees and costs that were expensed and included in general and administrative expenses. These charges are directly attributable to the transaction and represent non-recurring costs.

(3)
Represents debt assumption fees that were capitalized as deferred debt costs.

        In accordance with the accounting guidance applicable to acquisitions of the partner's ownership interests that result in consolidation of previously unconsolidated entities, the Company recorded all of the assets and liabilities of HCP Ventures II at their fair value as of the January 14, 2011 acquisition date. The Company utilized relevant market data and valuation techniques to allocate the acquisition date fair value for HCP Ventures II. Relevant market data and valuation techniques included, but were not limited to, market data comparables for capitalization and discount rates, credit spreads and property specific cash flows assumptions. The capitalization and discount rates as well as credit spread assumptions utilized in the Company's valuation model were based on information that it believes to be within a reasonable range of current market data. The following table summarizes the fair values of the HCP Ventures II assets acquired and liabilities assumed as of the acquisition date of January 14, 2011 (in thousands):

Assets acquired
   
 

Buildings and improvements

  $ 683,033  

Land

    80,180  

Cash

    2,585  

Restricted cash

    1,861  

Intangible assets

    78,293  
       

Total assets acquired

  $ 845,952  
       

Liabilities assumed

       

Mortgage debt

  $ 635,182  

Other liabilities

    2,228  
       

Total liabilities assumed

    637,410  
       

Net assets acquired

  $ 208,542  
       

        The related assets, liabilities and results of operations of HCP Ventures II are included in the consolidated financial statements from the date of acquisition, January 14, 2011.

  • Summary of Unconsolidated Joint Venture Information

        The Company owns interests in the following entities that are accounted for under the equity method at December 31, 2011 (dollars in thousands):

Entity(1)
  Investments   Investment(2)   Ownership%

HCR ManorCare

  post-acute/skilled nursing operations   $ 97,763   9.9(3)

HCP Ventures III, LLC

  13 medical office buildings ("MOBs")     8,720   30

HCP Ventures IV, LLC

  54 MOBs and 4 hospitals     35,272   20

HCP Life Science(4)

  4 life science facilities     66,522   50 - 63

Horizon Bay Hyde Park, LLC

  1 senior housing development     7,086   72

Suburban Properties, LLC

  1 MOB     7,736   67

Advances to unconsolidated joint ventures, net

        953    
             

 

      $ 224,052    
             

Edgewood Assisted Living Center, LLC

  1 senior housing facility   $ (356 ) 45

Seminole Shores Living Center, LLC

  1 senior housing facility     (608 ) 50
             

 

      $ (964 )  
             

(1)
These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. See Note 2 regarding the Company's accounting principles of consolidation.
(2)
Represents the carrying value of the Company's investment in the unconsolidated joint venture. See Note 2 regarding the Company's accounting policy for joint venture interests.

(3)
Subject to dilution of certain equity awards, the ownership percentage is approximately 9.3%. See discussion of the HCR ManorCare Acquisition in Note 3.

(4)
Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships: (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

        Summarized combined financial information for the Company's unconsolidated joint ventures follows (in thousands):

 
  December 31,  
 
  2011(1)   2010(2)  

Real estate, net

  $ 3,806,187   $ 1,633,209  

Goodwill

    3,243,100      

Other assets, net

    2,554,590     131,714  
           

Total assets

  $ 9,603,877   $ 1,764,923  
           

Capital lease obligations and other debt

  $ 6,373,500   $  

Mortgage debt

    498,243     1,148,839  

Accounts payable

    1,083,581     32,120  

Other partners' capital

    1,465,536     415,697  

HCP's capital(3)

    183,017     168,267  
           

Total liabilities and partners' capital

  $ 9,603,877   $ 1,764,923  
           

(1)
Includes the financial information of HCR ManorCare, in which the Company acquired an interest for $95 million that represented a 9.3% equity interest (adjusted for dilution for certain equity awards) on April 7, 2011.

(2)
Includes the financial information of HCP Ventures II, which was consolidated on January 14, 2011.
(3)
The combined basis difference of the Company's investments in these joint ventures of $39 million, as of December 31, 2011, is primarily attributable to goodwill, real estate, capital lease obligations, deferred tax assets and lease related net intangibles.

 
  Year Ended December 31,(1)  
 
  2011(2)   2010   2009  

Total revenues

  $ 4,388,376   $ 172,972   $ 184,102  

Net loss(3)(4)

    (827,306 )   (54,237 )   (341 )

HCP's share in earnings(3)(4)

    46,750     4,770     3,511  

HCP's impairment of its investment in HCP Ventures II(4)

        (71,693 )    

Fees earned by HCP

    2,073     4,666     5,312  

Distributions received by HCP

    5,681     9,738     14,142  

(1)
Includes the financial information of HCP Ventures II, through January 14, 2011, at which time it was consolidated.

(2)
Includes the financial information of HCR ManorCare, in which the Company acquired an interest for $95 million that represented a 9.3% equity interest (adjusted for dilution for certain equity awards) on April 7, 2011.

(3)
The combined net loss for the year ended December 31, 2011, includes impairments, net of the related tax benefit, of $865 million related to HCR ManorCare's goodwill and intangible assets. The impairments at the operating entity were the result of reduced cash flows primarily caused by the reimbursement reductions for the Medicare skilled nursing facility Prospective Payment System announced by the Centers for Medicare & Medicaid Services (CMS) effective October 1, 2011. These reimbursement reductions were previously considered in the Company's underwriting assumptions for its initial investments in the operations of HCR ManorCare; therefore, the impairments are not considered to be part of the Company's basis in its investment. As such, HCR ManorCare's impairments during the year ended December 31, 2011 did not have an impact on the Company's share of earnings from or its investment in HCR ManorCare.

(4)
Net loss for the year ended December 31, 2010, includes an impairment of $54.5 million related to straight-line rent assets of HCP Ventures II (the "Ventures"). Concurrently, during the year ended December 31, 2010 HCP recognized a $71.7 million impairment of its investment in the Ventures that was primarily attributable to a reduction in the fair value of the Ventures' real estate assets and includes the Company's share of the impact of the Ventures' impairment of its straight-line rent assets. Therefore, HCP's share in earnings for the year ended December 31, 2010 does not include the impact of the Ventures' impairment of its straight-line rent assets.